Vesper Bio ApS
PrivateLast Round
Series A
Oct 31, 2025
Total Funding Raised
$5.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vesper Bio ApS is a clinical-stage biotechnology company that develops small-molecule sortilin inhibitors as oral treatments for neurodegenerative and neuropsychiatric diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vesper Bio ApS Comparables
Compare Vesper Bio ApS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sortina Pharma | 83% | |
| Arkuda Therapeutics | 80% | |
| Alector | 77% |
Vesper Bio ApS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 31, 2025 | ||||
| Grant | Oct 14, 2025 | ||||
| Grant | Jan 23, 2024 | ||||
| Seed | Oct 20, 2015 |
Vesper Bio ApS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Association for Frontotemporal Degeneration | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 31, 2025
$87M round closed.
- Oct 14, 2025
Secured $2.5M from Alzheimer's Drug Discovery Foundation and AFTD.
Vesper Bio ApS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vesper Bio ApS's valuation, stock price, and market status.
Is Vesper Bio ApS a public or private company?
Vesper Bio ApS is a private company.
What is the current stock price of Vesper Bio ApS?
Vesper Bio ApS is a private company with no public stock price. No recent secondary market data is available.
How much is Vesper Bio ApS worth (valuation)?
Valuation information for Vesper Bio ApS is not publicly available.
Can I buy Vesper Bio ApS stock?
Vesper Bio ApS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Vesper Bio ApS's last funding round?
Vesper Bio ApS's most recent funding round was Series A on October 31, 2025.
Who are the main investors in Vesper Bio ApS?
Key investors in Vesper Bio ApS include The Association for Frontotemporal Degeneration, The Michael J. Fox Foundation for Parkinson's Research, Alzheimer's Drug Discovery Foundation.
Will Vesper Bio ApS IPO soon?
No public IPO plans have been announced for Vesper Bio ApS.
How can I track Vesper Bio ApS secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vesper Bio ApS's secondary market activity and sign up for updates.